The Erythropoietin (EPO) Panel is a laboratory test conducted to measure the levels of erythropoietin hormone in the blood. Erythropoietin is a hormone produced by the kidneys that regulates the production of red blood cells. This test is usually conducted to determine whether a person has anaemia, kidney disease, or a bone marrow disorder. The EPO test is commonly used in sports to detect the use of performance-enhancing drugs, such as erythropoietin itself. Symptoms of low erythropoietin Symptoms of low erythropoietin levels include fatigue, shortness of breath, headaches, dizziness, pale skin, and cold hands and feet due to low oxygen levels in the body. Symptoms of high erythropoietin levels include excessive red blood cell production, which may lead to an increased risk of blood clots, stroke, and heart attack. Test Procedure The Erythropoietin (EPO) Panel test requires a blood sample from the patient. The procedure involves inserting a needle into a vein in the arm or hand and drawing out a small amount of blood. The blood sample is then sent to a laboratory for analysis. The test procedure involves analyzing the erythropoietin levels in the blood sample taken from the patient. The results of the test are usually available within 48 hours. Treatment Treatment options for low erythropoietin levels depend on the underlying condition causing the deficiency. In the case of kidney disease, treatment may involve addressing the underlying cause of the condition. In the case of anaemia, treatment may involve iron supplements or a blood transfusion. For high erythropoietin levels, treatment may involve medication to reduce the production of red blood cells. Booking the Erythropoietin (EPO) Panel Test on Apollo 24|7 Booking the Erythropoietin (EPO) Panel test on Apollo 24|7 is simple and convenient. Simply visit the website and select the Erythropoietin (EPO) Panel test from the list of available tests. Follow the instructions provided to book a slot for the test at a nearby Apollo laboratory. The results of the test are usually available within 48 hours. Early Diagnosis and Treatment Early diagnosis and treatment of erythropoietin-related conditions can provide numerous benefits, including improving overall health and quality of life, reducing the risk of complications, and preventing long-term damage to organs such as the kidneys or heart.